Current partner codePEPTIDESDE

Industry sponsor intelligence

Qilu Pharmaceutical Co., Ltd.Clinical Pipeline.

Lead-sponsor view of Qilu Pharmaceutical Co., Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.

Total
1
Recruiting
0
Active
1
Completed
0
Results posted
0
Avg enrollment
282

Pipeline overview

Programs by phase and activity.

Velocity

Qilu Pharmaceutical Co., Ltd. trials by start year

Study start year · indexed snapshot

1110020252025: 1 trials

Development

Trials by phase

Early Phase 10
Phase 10
Phase 20
Phase 31
Phase 40
ProductStudiesEarly / IPhase IIPhase IIIPhase IVActive
Abaloparatide100101
Teriparatide100101

Active peptide trials

In motion now.

Completed trials

Finished registry records.

No studies in this snapshot.

Search sponsor records

All Qilu Pharmaceutical Co., Ltd. studies.

This page groups studies where Qilu Pharmaceutical Co., Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.

1 matching study